Home/Filings/4/0001142576-10-000041
4//SEC Filing

Shue Youe Kong 4

Accession 0001142576-10-000041

CIK 0001142576other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:45 PM ET

Size

5.0 KB

Accession

0001142576-10-000041

Insider Transaction Report

Form 4
Period: 2010-11-15
Shue Youe Kong
VP, clinical Development
Transactions
  • Other

    Common stock

    2010-11-15$7.71/sh+1,453$11,20291,560 total
Footnotes (1)
  • [F1]Acquired under the Company's employee stock purchase plan on November 15, 2010.

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1
  • filerCIK 0001380841

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:45 PM ET
Size
5.0 KB